Skip to content
Eric J. Huselton, M.D.

Eric J. Huselton, M.D.

Hematology & Oncology , Cancer

5 out of 5 stars
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

About Me

Dr. Eric Huselton received his medical degree from SUNY Downstate College of Medicine in 2012. He completed an Internal Medicine Residency Training Program and a Hematology/Oncology Fellowship at Washington University in Saint Louis/Bames Jewish Hospital in 2015 and 2018, respectively. Dr. Huselton ...
Dr. Eric Huselton received his medical degree from SUNY Downstate College of Medicine in 2012. He completed an Internal Medicine Residency Training Program and a Hematology/Oncology Fellowship at Washington University in Saint Louis/Bames Jewish Hospital in 2015 and 2018, respectively. Dr. Huselton is certified by the American Board of Internal Medicine.

Dr. Huselton is an Assistant Professor in the Division of Hematology and Oncology at the University of Rochester School of Medicine and Dentistry.

Dr. Huselton's special interests include allogenic hematopoietic cell transplant, haploidentical hematopoietic cell transplant, AML, MDS and hematologic malignancies. He aims to provide the best care by incorporating new treatments based on the most recent data, including clinical trials, targeted therapies, immunotherapy and cellular therapies. Dr. Huselton's hobbies include sailing, hiking and cooking.

Certified Specialties

Hematology - American Board of Internal Medicine

Internal Medicine - American Board of Internal Medicine

Medical Oncology - American Board of Internal Medicine

Faculty Appointments

Associate Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematology & Oncology, Washington University In St. Louis (USA). 2015 - 2018

Residency, Internal Medicine, Washington University in St. Louis. 2013 - 2015

Internship, Internal Medicine, Washington University in St. Louis. 2012 - 2013

Education

MD | SUNY Downstate Health Sciences University - College of Medicine. 2012

Awards

Wilmot Fellowship Award. 2019 - 2022

Travel Award, Society of Hematologic Oncology. 2016

Harold A. Lyons Award for Excellence in Clinical Medicine. 2012

Alpha Omega Alpha. 2011

Downstate Alumni Summer Research Fellow. 2009

Publications

Journal Articles

Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

LoCastro M, Baran A, Liesveld J, Huselton E, Hill E, Loh KP, Mendler JH

JCO oncology practice.. 2024 December 16 :OP2400556. Epub 12/16/2024.

Clinicians' Perspectives on the Telehealth Serious Illness Care Program for Older Adults With Myeloid Malignancies: Single-Arm Pilot Study.

LoCastro M, Wang Y, Yu T, Mortaz-Hedjri S, Mendler J, Norton S, Bernacki R, Carroll T, Klepin H, Wedow L, Goonan S, Erdos H, Bagnato B, Liesveld J, Huselton E, Kluger B, Loh KP

JMIR formative research.. 2024 June 278 :e58503. Epub 06/27/2024.

Patient-oncologist discussion of treatment decisions: Exploring the role of a patient-centered communication tool for older adults with acute myeloid leukemia and their caregivers.

Jensen-Battaglia M, LoCastro M, Oh H, Sanapala C, Flannery M, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2024 June 15 (5):101716. Epub 02/09/2024.

Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia.

LoCastro M, Jensen-Battaglia M, Sanapala C, Rodenbach R, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2024 June 15 (5):101793. Epub 05/11/2024.

Exercise and inflammatory cytokine regulation among older adults with myeloid malignancies.

Loh KP, Wang Y, Sanapala C, Gilmore N, Netherby-Winslow C, Mendler JH, Liesveld J, Huselton E, Williams AM, Klepin HD, Jensen-Battaglia M, Mustian K, Vertino P, Susiarjo M, Janelsins MC

Experimental gerontology.. 2024 March 187 :112364. Epub 01/25/2024.

Telehealth serious illness care program for older adults with hematologic malignancies: a single-arm pilot study.

Locastro M, Mortaz Hedjri S, Wang Y, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Liesveld JL, Huselton EJ, Kluger B, Loh KP

Blood advances.. 2023 December 267 (24):7597-7607. Epub 1900 01 01.

Association of crystalloid fluid infusion with intravascular hemolysis and organ dysfunction in hematopoietic stem cell transplant patients.

Holloway MR, Fountaine T, Henrichs K, Feeney T, Andolina J, O'Dwyer K, Liesveld J, Blumberg N, Huselton E

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.. 2023 June 62 (3):103641. Epub 01/13/2023.

Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.

LoCastro M, Wang Y, Sanapala C, Jensen-Battaglia M, Wittink M, Norton S, Klepin HD, Richardson DR, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2023 June 14 (5):101529. Epub 05/25/2023.

Exercise and epigenetic ages in older adults with myeloid malignancies.

Loh KP, Sanapala C, Jensen-Battaglia M, Rana A, Sohn MB, Watson E, Gilmore N, Klepin HD, Mendler JH, Liesveld J, Huselton E, LoCastro M, Susiarjo M, Netherby-Winslow C, Williams AM, Mustian K, Vertino P, Janelsins MC

European journal of medical research.. 2023 May 3028 (1):180. Epub 05/30/2023.

Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.

Locastro M, Sanapala C, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Watson EE, Liesveld JL, Huselton EJ, O'Dwyer KM, Baran AM, Flannery M, Kluger B, Loh KP

Blood advances.. 2023 May 97 (9):1871-1884. Epub 1900 01 01.

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation.

Rashidi A, Huselton EJ, Stefanski HE, DeFor TE, Shanley R, Choi J, DiPersio JF, Juckett M, Miller JS, Weisdorf DJ, Schroeder MA

Transplantation and cellular therapy.. 2023 May 29 (5):328.e1-328.e6. Epub 02/19/2023.

Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.

LoCastro M, Sanapala C, Wang Y, Jensen-Battaglia M, Wittink M, Norton S, Klepin HD, Richardson DR, Mendler JH, Liesveld J, Huselton E, O'Dwyer K, Cortes AM, Rodriguez C, Dale W, Loh KP

Cancer medicine. 2023 April 12 (7):8581-8593. Epub 12/19/2022.

Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes.

LoCastro M, Sanapala C, Mendler JH, Norton S, Bernacki R, Carroll T, Klepin H, Watson E, Liesveld J, Huselton E, O'Dwyer K, Baran A, Flannery M, Kluger BM, Loh KP

Journal of geriatric oncology.. 2023 January 14 (1):101374. Epub 09/10/2022.

Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.

Manogna D, Lipof JJ, Baran AM, Said B, Becker MW, Mendler JH, Aljitawi OS, O'Dwyer KM, Huselton E, Burack R, Blaney M, Liesveld JL, Loh KP

Journal of geriatric oncology.. 2023 January 14 (1):101403. Epub 11/10/2022.

Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.

Watson EE, Sanapala C, Cortes AM, Klepin HD, Wittink M, Norton SA, Richardson DR, Dale W, Magnuson A, Mendler JH, Liesveld JL, Huselton EJ, O'Dwyer KM, LeBlanc TW, El-Jawahri A, Wong M, Loh KP

Blood advances.. 2022 November 86 (21):5707-5710. Epub 1900 01 01.

A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.

Loh KP, Sanapala C, Watson EE, Jensen-Battaglia M, Janelsins MC, Klepin HD, Schnall R, Culakova E, Vertino P, Susiarjo M, Lin PJ, Mendler JH, Liesveld JL, Huselton EJ, Taberner K, Mohile SG, Mustian K

Blood advances.. 2022 July 126 (13):3850-3860. Epub 1900 01 01.

Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2).

Loh KP, Sanapala C, Janelsins M, Klepin HD, Schnall R, Culakova E, Sohn MB, Vertino P, Susiarjo M, Jensen-Battaglia M, Becker MW, Liesveld J, Mendler JH, Huselton E, Lin PJ, Mustian K

Journal of geriatric oncology.. 2022 May 13 (4):545-553. Epub 12/21/2021.

Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.

Eastburg L, Russler-Germain DA, DiPersio JF, Fountaine T, Andolina JR, Abboud R, Huselton E

Leukemia & lymphoma.. 2022 January 63 (1):222-226. Epub 11/18/2021.

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.

Locastro M, Baran A, Liesveld JL, Huselton EJ, Becker MW, O'Dwyer KM, Aljitawi OS, Baumgart M, Snyder E, Kluger B, Loh KP, Mendler JH

Blood advances.. 2021 December 285 (24):5554-5564. Epub 1900 01 01.

Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS.

Huselton E, Rettig MP, Campbell K, Cashen AF, DiPersio JF, Gao F, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Marcus S, Westervelt P

Leukemia research.. 2021 November 110 :106713. Epub 09/22/2021.

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes.

Huselton E, Rettig MP, Fletcher T, Ritchey J, Gehrs L, McFarland K, Christ S, Eades WC, Trinkaus K, Romee R, Kulkarni S, Ghobadi A, Abboud C, Cashen AF, Stockerl-Goldstein K, Uy GL, Vij R, Westervelt P, DiPersio JF, Schroeder MA

Leukemia & lymphoma.. 2021 June 62 (6):1441-1449. Epub 01/19/2021.

A Case of Acute Eosinophilic Leukemia with a Novel 6 Mutation.

Lipof JJ, Huselton EJ, Zent CS, Evans A, Zhang B, Rothberg PG, Bennett JM

Case reports in hematology.. 2021 2021 :5574766. Epub 07/03/2021.

Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report.

Superdock M, Komisarof J, Katerji H, Huselton E

Case reports in oncology.. 2021 14 (3):1621-1626. Epub 11/12/2021.

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.

Schroeder MA, Fiala MA, Huselton E, Cardone MH, Jaeger S, Jean SR, Shea K, Ghobadi A, Wildes T, Stockerl-Goldstein KE, Vij R

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2019 July 125 (13):3776-3783. Epub 04/05/2019.

Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation.

Huselton E, Slade M, Trinkaus KM, DiPersio JF, Westervelt P, Romee R

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2018 October 24 (10):2047-2055. Epub 05/24/2018.

Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation.

Huselton E, Slade M, DiPersio JF, Westervelt P, Vij R, Uy GL, Fehniger TA, Abboud CN, Gao F, Schroeder MA, Romee R

Bone marrow transplantation.. 2017 May 52 (5):769-771. Epub 01/09/2017.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

5.0 stars

During this visit, did this provider show respect for what you had to say?

5.0 stars

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9 stars

During this visit, did this provider listen carefully to you?

5.0 stars

During this visit, did this provider explain things in a way that was easy to understand?

5.0 stars

Patient Comments

Dr. Eric J. Huselton has been very helpful and informative of the risks and consequences of this stem cell transplant.

Sep 22, 2024

I appreciated that the Doctor/Nurse did not try to sway me one way or the other when I came to my treatment options.

Jun 09, 2024

5.0 stars

Of all the many specialists I have seen recently, Dr. Huselton rates highest! As soon as he walked in my room, I felt at ease. He treated me and my concerns with the utmost attention. He answered all my questions and his explanations were delivered at a level my husband and I could clearly comprehend. I would certainly give him a Strong Star!

Jun 05, 2024

5.0 stars

Dr Huselton is a consument professional with a heart of gold

May 22, 2024

5.0 stars

The entire experience was, in my opinion, excellent! Beginning with the clerks and receptionists to the providers and their teams. The information I received was quite informative and relieved my concerns as to how I could manage my particular issues.

May 20, 2024

5.0 stars

I have made recommendations for friends to use Dr. Huselton.

May 08, 2024

5.0 stars

Dr. Huselton has always treated me as though I am his only patient. He is fully present every time I see him and he treats me as though he has no where to be but there with me addressing all of my questions and concerns.

May 04, 2024

5.0 stars

Dr. Hustleton is a wonderful doctor who takes great care with me, is very easy to talk to, and keeps me fully informed about my care.

Feb 18, 2024

5.0 stars

All good

Sep 17, 2023

5.0 stars

Great nurse and doctors.

Aug 31, 2023

5.0

Dr Huselton is a great doctor I would recommend him very highly.

Aug 04, 2023

5.0

No bad experience

Jul 26, 2023

5.0

I can't say enough about Dr. Huselton , he was forthcoming, very professional, and informative.

Jun 15, 2023

5.0

My reason for the visit was not entirely clear to me and the provider had little information about the referral. He and the RN were both very patient and thorough in determining the reason for the referral and helping me to understand everything.

May 12, 2023

5.0

Dr. Huselton is simply amazing and I would recommend him to anybody I knew. This last visit he reminded me that I am one of the few success stories and that I am simply wonderful with my positive attitude throughout that last 2 years.

May 07, 2023

5.0

Dr. Huselton is an outstanding doctor who I have the utmost faith in.

Mar 27, 2023

5.0

My first visit to a new hemotologist since moving to NY. Very pleased

Mar 14, 2023

5.0

All good! A very difficult prognosis was handled with extreme care and concern by all medical faculty

Mar 10, 2023

5.0

Good experience

Feb 26, 2023

Dr Huselton's care and concern is always very reassuring and comforting

Jan 20, 2023

Both Beth and Dr Huselton are great.

Jan 12, 2023

5.0

Dr. Huselton is exceptional!

Dec 07, 2022

5.0

Given my condition and the uncertainty of my health Dr. Huselton was great.

Nov 04, 2022

5.0

Very good care.

Oct 31, 2022

5.0

Dr. Huselton's care for me was exceptional while in treatment. Clearly cares very much about patients and his profession. THANK you.

Oct 27, 2022

5.0

Dr Huselton was great!!! Very professional yet personable and attentive!!!

Sep 20, 2022

5.0

I can't say enough good things about Dr. Huselton and his team.

Sep 04, 2022

5.0

Good experience

Aug 15, 2022

I feel very confident with Dr. Huselton

Jul 09, 2022

5.0

No bad experience

May 27, 2022

5.0

Dr. H went over everything

Mar 13, 2022

Dr. Huselton is great. He took my from deaths door (Leukemia) to complete remission. I feel great and it's all because of what Dr. O'Dwyer and then Dr. Huselton have done for me.

Mar 04, 2022

5.0

Good experience

Feb 20, 2022

4.2

Liked the care provider

Feb 13, 2022